QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DURING PREGNANCY - RELATIONSHIP OF VIRAL TITER TO MOTHER-TO-CHILD TRANSMISSION AND STABILITY OF VIRAL LOAD
B. Weiser et al., QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DURING PREGNANCY - RELATIONSHIP OF VIRAL TITER TO MOTHER-TO-CHILD TRANSMISSION AND STABILITY OF VIRAL LOAD, Proceedings of the National Academy of Sciences of the United Statesof America, 91(17), 1994, pp. 8037-8041
To develop strategies to prevent mother-to-child transmission of human
immunodeficiency virus type 1 (HIV-1), it is important to define the
factors determining it. We examined the relationship between maternal
HIV-1 titer and the occurrence of mother-to-child transmission. In add
ition, we quantitated HIV-1 longitudinally in mothers during pregnancy
, at delivery, and up to 1 year postpartum. To examine transmission, w
e prospectively studied 19 mother-child pairs; in 5 pairs, HIV-1 trans
mission occurred. We used endpoint dilution culture of peripheral bloo
d mononuclear cells to determine maternal viral titer and found that a
lthough 4 of 6 (67%) women with viral titers of greater than or equal
to 125 HIV-1 infectious units per 10(6) cells transmitted HIV-1 to the
ir infants, only 1 of 13 (7.6%) women with lower viral titers transmit
ted (P = 0.01). Twelve of the 19 mothers had HIV-1 loads determined se
rially 3-8 times over periods ranging from 18 to 65 weeks. Viral titer
s varied greatly between the 12 women, but the viral load in each woma
n remained stable over time. In this cohort, HIV-1 viral load remained
stable during pregnancy and the greater the maternal viral burden, th
e more likely that transmission occurred. These two related findings s
uggest that determination of HIV-1 titers early in pregnancy may predi
ct which women are at high risk of transmitting to their infants and m
ay be used to counsel HIV-1-infected women of childbearing age, These
data identify maternal viral titer as a major determinant of mother-to
-child HIV-1 transmission and thereby provide the scientific rationale
for therapeutic strategies designed to interrupt transmission by lowe
ring viral load.